147031-85-4 Usage
Uses
Used in Pharmaceutical Industry:
2,3-Dihydro-1,4-benzodioxine-2-carbothioamide is used as a building block for the synthesis of various compounds due to its unique structure and pharmaceutical potential.
Used in Anti-tubercular Applications:
2,3-Dihydro-1,4-benzodioxine-2-carbothioamide is used as an anti-tubercular agent, showing promise in the development of new treatments for tuberculosis.
Used in Anti-inflammatory Applications:
2,3-Dihydro-1,4-benzodioxine-2-carbothioamide is used as a potential anti-inflammatory agent, being studied for its ability to reduce inflammation and alleviate symptoms associated with inflammatory conditions.
Used in Neurodegenerative Disease Treatment:
2,3-Dihydro-1,4-benzodioxine-2-carbothioamide is used as a potential therapeutic agent for the treatment of neurodegenerative diseases, being investigated for its ability to slow down or halt the progression of these conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 147031-85-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,7,0,3 and 1 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 147031-85:
(8*1)+(7*4)+(6*7)+(5*0)+(4*3)+(3*1)+(2*8)+(1*5)=114
114 % 10 = 4
So 147031-85-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H9NO2S/c10-9(13)8-5-11-6-3-1-2-4-7(6)12-8/h1-4,8H,5H2,(H2,10,13)
147031-85-4Relevant academic research and scientific papers
Amide-Oximes et hydroximates benzodioxaniques: synthese de nouveaux composes et etude en neuropsycho-pharmacologie
Davrinche, C,Nguyen-Tri-Xuong, E,Hamad, Y El,Reynaud, P,Rinjard, P,Tran, G
, p. 765 - 778 (2007/10/02)
Amide-oximes and benzodioxanic hydroximates: synthesis of new compounds and neuropsychopharmacological study.The authors describe the ON-(dialkylaminoalkyl) amide-oximes, benzodioxanic hydroximates and also the acetylated derivatives of the former compounds (I) which are detoxified.The hydroximates are obtained without structural ambiguity from thionoesters.Pharmacological testing via the main methods shows that some of these new compounds possess imipraminic, and others neuroleptic properties. benzodioxane/ amide-oxime / hydroximate / antidepressant / neuroleptic /
